41 related articles for article (PubMed ID: 16641212)
1. miRNA signatures in childhood sarcomas and their clinical implications.
Viera GM; Salomao KB; de Sousa GR; Baroni M; Delsin LEA; Pezuk JA; Brassesco MS
Clin Transl Oncol; 2019 Dec; 21(12):1583-1623. PubMed ID: 30949930
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing's sarcoma survivors: A scoping review.
Horiuchi K; Nemoto R; Mizuno T; Susa M; Chiba K
J Bone Oncol; 2023 Feb; 38():100464. PubMed ID: 36560961
[TBL] [Abstract][Full Text] [Related]
3. Individual Trajectories of Bone Mineral Density Reveal Persistent Bone Loss in Bone Sarcoma Patients: A Retrospective Study.
Avnet S; Falzetti L; Bazzocchi A; Gasperini C; Taddei F; Schileo E; Baldini N
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143059
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives.
Rossi F; Tortora C; Paoletta M; Marrapodi MM; Argenziano M; Di Paola A; Pota E; Di Pinto D; Di Martino M; Iolascon G
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139510
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
van Atteveld JE; Mulder RL; van den Heuvel-Eibrink MM; Hudson MM; Kremer LCM; Skinner R; Wallace WH; Constine LS; Higham CE; Kaste SC; Niinimäki R; Mostoufi-Moab S; Alos N; Fintini D; Templeton KJ; Ward LM; Frey E; Franceschi R; Pavasovic V; Karol SE; Amin NL; Vrooman LM; Harila-Saari A; Demoor-Goldschmidt C; Murray RD; Bardi E; Lequin MH; Faienza MF; Zaikova O; Berger C; Mora S; Ness KK; Neggers SJCMM; Pluijm SMF; Simmons JH; Di Iorgi N
Lancet Diabetes Endocrinol; 2021 Sep; 9(9):622-637. PubMed ID: 34339631
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations.
van Atteveld JE; Verhagen IE; van den Heuvel-Eibrink MM; van Santen HM; van der Sluis IM; Di Iorgi N; Simmons JH; Ward LM; Neggers SJCMM
Cancer Med; 2021 Jul; 10(13):4177-4194. PubMed ID: 34100559
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density changes in a free vascularised fibular graft in the distal femoral bone after osteosarcoma in a 10-year-old boy: a 7-year follow-up.
Jørgensen AR; Jørgensen PH; Jul Kiil B; Stilling M
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762269
[TBL] [Abstract][Full Text] [Related]
8. Low bone mineral density in children and adolescents with cancer.
Jin HY; Lee JA
Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):137-144. PubMed ID: 33017885
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density.
Lim SW; Ahn JH; Choi A; Cho WH; Lee JA; Kim DH; Seo JH; Lim JS
Ann Pediatr Endocrinol Metab; 2016 Mar; 21(1):21-5. PubMed ID: 27104175
[TBL] [Abstract][Full Text] [Related]
10. Do Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?
Hobusch GM; Tiefenboeck TM; Patsch J; Krall C; Holzer G
Clin Orthop Relat Res; 2016 Jun; 474(6):1508-15. PubMed ID: 26883654
[TBL] [Abstract][Full Text] [Related]
11. Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?
Hobusch GM; Noebauer-Huhmann I; Krall C; Holzer G
Clin Orthop Relat Res; 2014 Nov; 472(11):3471-9. PubMed ID: 25015839
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management.
Kang MJ; Lim JS
Korean J Pediatr; 2013 Feb; 56(2):60-7. PubMed ID: 23482662
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.
Pirker-Frühauf UM; Friesenbichler J; Urban EC; Obermayer-Pietsch B; Leithner A
Clin Orthop Relat Res; 2012 Oct; 470(10):2874-85. PubMed ID: 22806259
[TBL] [Abstract][Full Text] [Related]
14. Serum tumor markers in pediatric osteosarcoma: a summary review.
Savitskaya YA; Rico-Martínez G; Linares-González LM; Delgado-Cedillo EA; Téllez-Gastelum R; Alfaro-Rodríguez AB; Redón-Tavera A; Ibarra-Ponce de León JC
Clin Sarcoma Res; 2012 Mar; 2():9. PubMed ID: 22587902
[TBL] [Abstract][Full Text] [Related]
15. Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.
Müller C; Winter CC; Rosenbaum D; Boos J; Gosheger G; Hardes J; Vieth V
BMC Musculoskelet Disord; 2010 Dec; 11():287. PubMed ID: 21190557
[TBL] [Abstract][Full Text] [Related]
16. Pediatric DXA: clinical applications.
Binkovitz LA; Sparke P; Henwood MJ
Pediatr Radiol; 2007 Jul; 37(7):625-35. PubMed ID: 17431606
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and bone metabolism in children treated for bone sarcomas.
Ruza E; Sierrasesúmaga L; Azcona C; Patiño-Garcia A
Pediatr Res; 2006 Jun; 59(6):866-71. PubMed ID: 16641212
[TBL] [Abstract][Full Text] [Related]
18. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
